HR 4832 · 107th Congress 2001–2003, ended

Prescription Drug Comparative Effectiveness Act of 2002

Introduced May 23, 2002 Originated House Sponsor Thomas H. Allen D-ME

Fact sheet Spreadsheet

Latest action · Jun 3, 2002 Referred to the Subcommittee on Health.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedMay 23, 2002
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Prescription Drug Comparative Effectiveness Act of 2002 - Directs the Director of the Agency for Healthcare Research and Quality to study, analyze, and report to Congress on valid scientific evidence regarding the comparative effectiveness and cost-effectiveness, relative to other drugs and treatments, of prescription drugs that account for high levels of expenditures or use by individuals entitled to benefits under titles XVIII (Medicare) or XIX (Medicaid) of the Social Security Act.

Cosponsors 19

Members who signed on, in the order they did. Signatures ran from May 23, 2002 to Sep 18, 2002; 9 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
D-NYCharles B. RangelOriginalMay 23, 2002
D-CAFortney Pete StarkOriginalMay 23, 2002
D-CAHenry A. WaxmanOriginalMay 23, 2002
D-RIJames R. LangevinOriginalMay 23, 2002
D-MEJohn Elias BaldacciOriginalMay 23, 2002
D-OHMarcy KapturOriginalMay 23, 2002
D-ARMarion BerryOriginalMay 23, 2002
D-CTRosa L. DeLauroOriginalMay 23, 2002
D-OHSherrod BrownOriginalMay 23, 2002
D-MAJohn F. TierneyJun 6, 2002
D-TXMartin FrostJun 6, 2002
D-TXMax SandlinJun 6, 2002
D-MORichard A. GephardtJun 6, 2002
D-WIThomas M. BarrettJun 6, 2002
D-MIDavid E. BoniorJun 20, 2002
D-DCEleanor Holmes NortonJun 20, 2002
D-FLKaren L. ThurmanJun 20, 2002
D-NYLouise McIntosh SlaughterJul 9, 2002
D-CAGeorge MillerSep 18, 2002

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred May 23, 2002
Health Subcommittee
Referred Jun 3, 2002

Actions 3

Everything that happened, newest first.

  1. Jun 3, 2002Referred to the Subcommittee on Health.
  2. May 23, 2002Introduced in House
  3. May 23, 2002Referred to the House Committee on Energy and Commerce.

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To require the Director of the Agency for Healthcare Research and Quality to conduct studies on the comparative effectiveness and cost-effectiveness of prescription drugs that account for high levels of expenditures or use by individuals eligible for Medicare or Medicaid, and for other purposes.
Short Titles as Introduced
Prescription Drug Comparative Effectiveness Act of 2002

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. May 23, 2002Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

$1 $5 $10

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.